MENU

THTX Stock Tickeron detected bullish Stock Pattern: Cup-and-Handle THTX on October 14, 2024, netting in a 2.69% gain over 3 days

A.I.dvisor
at Tickeron.com
10/19/24
Loading...
+2.69% Gain from a Successful pattern Cup-and-Handle
THTX - Theratechnologies
Tickeron
Ticker: THTX
Company: Theratechnologies
Gain: +2.69%
Confirmed: 10/14/24
Succeeded: 10/17/24
Total length: 3 days
On October 14, 2024, A.I.dvisor detected a Cup-and-Handle Pattern (Bullish) for Theratechnologies (THTX, $1.25). On October 14, 2024, A.I.dvisor confirmed the Bullish pattern, setting a target price of $1.32. 3 days later, on October 17, 2024, THTX reached the target price resulting in a for traders who took a long position in the stock.

THTX in +4.53% Uptrend, growing for three consecutive days on October 10, 2024

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where THTX advanced for three days, in of 211 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where THTX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 08, 2024. You may want to consider a long position or call options on THTX as a result. In of 112 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for THTX just turned positive on October 04, 2024. Looking at past instances where THTX's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

THTX moved above its 50-day moving average on October 15, 2024 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where THTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

THTX broke above its upper Bollinger Band on October 18, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for THTX entered a downward trend on October 18, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. THTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (12.594). P/E Ratio (0.000) is within average values for comparable stocks, (111.595). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.971). THTX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.584) is also within normal values, averaging (224.025).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. THTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
THTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV)

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2015, rue Peel
Phone
+1 514 336-7800
Employees
58
Web
https://www.theratech.com